(CCEP) Coca-Cola European - NASDAQ
Sector: Consumer Defensive | Industry: Beverages - Non-Alcoholic | Exchange: NASDAQ (USA) | Market Cap: 42.945m USD | Total Return: 7.4% in 12m
Avg Turnover: 191M
EPS Trend: -34.8%
Qual. Beats: 0
Rev. Trend: 93.4%
Qual. Beats: 0
Warnings
Below Avwap Earnings
Tailwinds
No distinct edge detected
Coca-Cola Europacific Partners PLC (CCEP) is the world’s largest independent Coca-Cola bottler by revenue, operating across Europe, Australia, the Pacific, and Indonesia. The company manages the end-to-end supply chain, including the production, distribution, and marketing of an extensive portfolio that spans traditional soft drinks, energy drinks, water, and ready-to-drink alcoholic beverages.
The business model relies on a franchise system where CCEP purchases concentrate from The Coca-Cola Company and other brand owners to manufacture and sell finished products in exclusive territories. This capital-intensive model benefits from significant economies of scale and high barriers to entry within the consumer staples sector. Further insights into the companys long-term growth drivers are available on ValueRay.
Historically focused on Western Europe, the firm expanded its geographic footprint and market reach significantly following the 2021 acquisition of Coca-Cola Amatil. This strategic pivot transformed the entity into a multi-continental operation, diversifying its exposure across both mature and emerging beverage markets.
- Synergies from Asia-Pacific market integration drive long term revenue growth targets
- Fluctuating sugar taxes and environmental packaging regulations impact operating margins
- Input cost volatility for aluminum and PET plastics affects bottom line results
- Success of alcoholic and energy drink diversification shifts total brand valuation
- Consumer spending power in European markets dictates volume and premiumization trends
| Net Income: 1.94b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA -0.10 > 1.0 |
| NWC/Revenue: -7.21% < 20% (prev -7.39%; Δ 0.19% < -1%) |
| CFO/TA 0.10 > 3% & CFO 2.92b > Net Income 1.94b |
| Net Debt (10.4b) to EBITDA (3.42b): 3.04 < 3 |
| Current Ratio: 0.80 > 1.5 & < 3 |
| Outstanding Shares: last quarter (449.1m) vs 12m ago -2.37% < -2% |
| Gross Margin: 35.58% > 18% (prev 35.63%; Δ -0.06% > 0.5%) |
| Asset Turnover: 68.56% > 50% (prev 65.72%; Δ 2.84% > 0%) |
| Interest Coverage Ratio: 10.30 > 6 (EBIT TTM 2.79b / Interest Expense TTM 270.7m) |
| A: -0.05 (Total Current Assets 6.08b - Total Current Liabilities 7.58b) / Total Assets 29.9b |
| B: 0.30 (Retained Earnings 8.82b / Total Assets 29.9b) |
| C: 0.09 (EBIT TTM 2.79b / Avg Total Assets 30.5b) |
| D: 0.36 (Book Value of Equity 7.83b / Total Liabilities 21.6b) |
| Altman-Z'' = 1.63 = BB |
| DSRI: 0.95 (Receivables 2.78b/2.87b, Revenue 20.9b/20.4b) |
| GMI: 1.00 (GM 35.63% / 35.58%) |
| AQI: 1.02 (AQ_t 0.59 / AQ_t-1 0.58) |
| SGI: 1.02 (Revenue 20.9b / 20.4b) |
| TATA: -0.03 (NI 1.94b - CFO 2.92b) / TA 29.9b) |
| Beneish M = -3.04 (Cap -4..+1) = AA |
As of June 19, 2026, the stock is trading at USD 96.93 with a total of 3,004,349 shares traded.
Over the past week, the price has changed by -0.78%,
over one month by +4.89%,
over three months by +1.96% and
over the past year by +7.35%.
Coca-Cola European has received a consensus analysts rating of 4.00. Therefore, it is recommended to buy CCEP.
- StrongBuy: 7
- Buy: 2
- Hold: 4
- Sell: 0
- StrongSell: 1
| Analysts Target Price | 105.6 | 8.9% |
Market Cap EUR = 37.5b (42.9b USD * 0.8723 USD.EUR)
P/E Trailing = 19.6336
P/E Forward = 18.9753
P/S = 2.0574
P/B = 4.737
P/EG = 2.8004
Revenue TTM = 20.9b EUR
EBIT TTM = 2.79b EUR
EBITDA TTM = 3.42b EUR
Long Term Debt = 9.69b EUR (from longTermDebt, last quarter)
Short Term Debt = 470.0m EUR (from shortTermDebt, last quarter)
Debt = 11.4b EUR (from shortLongTermDebtTotal, last quarter) + Leases 699.0m
Net Debt = 10.4b EUR (calculated: Debt 11.4b - CCE 972.0m)
Enterprise Value = 47.9b EUR (37.5b + Debt 11.4b - CCE 972.0m)
Interest Coverage Ratio = 10.30 (Ebit TTM 2.79b / Interest Expense TTM 270.7m)
EV/FCF = 22.26x (Enterprise Value 47.9b / FCF TTM 2.15b)
FCF Yield = 4.49% (FCF TTM 2.15b / Enterprise Value 47.9b)
FCF Margin = 10.29% (FCF TTM 2.15b / Revenue TTM 20.9b)
Net Margin = 9.29% (Net Income TTM 1.94b / Revenue TTM 20.9b)
Gross Margin = 35.58% ((Revenue TTM 20.9b - Cost of Revenue TTM 13.5b) / Revenue TTM)
Gross Margin QoQ = 35.81% (prev 35.34%)
Tobins Q-Ratio = 1.60 (Enterprise Value 47.9b / Total Assets 29.9b)
Interest Expense / Debt = 2.38% (Interest Expense 270.7m / Debt 11.4b)
Taxrate = 22.97% (590.0m / 2.57b)
NOPAT = 2.15b (EBIT 2.79b * (1 - 22.97%))
Current Ratio = 0.80 (Total Current Assets 6.08b / Total Current Liabilities 7.58b)
Debt / Equity = 1.45 (Debt 11.4b / totalStockholderEquity, last quarter 7.83b)
Debt / EBITDA = 3.04 (Net Debt 10.4b / EBITDA 3.42b)
Debt / FCF = 4.84 (Net Debt 10.4b / FCF TTM 2.15b)
Total Stockholder Equity = 8.22b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.37% (Net Income 1.94b / Total Assets 29.9b)
RoE = 23.63% (Net Income TTM 1.94b / Total Stockholder Equity 8.22b)
RoCE = 15.57% (EBIT 2.79b / Capital Employed (Equity 8.22b + L.T.Debt 9.69b))
RoIC = 9.86% (NOPAT 2.15b / Invested Capital 21.8b)
WACC = 5.42% (E(37.5b)/V(48.9b) * Re(6.51%) + D(11.4b)/V(48.9b) * Rd(2.38%) * (1-Tc(0.23)))
Discount Rate = 6.51% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 33.86 | Cagr: -0.87%
[DCF] Terminal Value 74.70% ; FCFF base≈2.20b ; Y1≈2.11b ; Y5≈2.04b
[DCF] Fair Price = 49.00 (EV 32.1b - Net Debt 10.4b = Equity 21.7b / Shares 442.8m; r=8.35% [WACC [floored]]; 5y FCF grow -5.23% → 2.50% )
EPS Correlation: -34.77 | EPS CAGR: -15.18% | SUE: 0.0 | # QB: 0
Revenue Correlation: 93.40 | Revenue CAGR: 6.86% | SUE: -0.02 | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.00 | Chg30d=N/A | Revisions=N/A | Analysts=0
EPS next Quarter (2026-09-30): EPS=0.00 | Chg30d=N/A | Revisions=N/A | Analysts=0
EPS current Year (2026-12-31): EPS=4.46 | Chg30d=-0.11% | Revisions=+25% | GrowthEPS=+4.1% | GrowthRev=+2.8%
EPS next Year (2027-12-31): EPS=4.88 | Chg30d=+0.01% | Revisions=+9% | GrowthEPS=+9.5% | GrowthRev=+3.8%
[Analyst] Revisions Ratio: +25%